IP Library Granted Patent US 12,472,096
Granted Patent B2
US 12,472,096 · App. 17/423,419 · Granted Nov 18, 2025

Method and device for treating eye disease

Inventors: Rui Jing Jiang (Lexington, MA); Brandon Wei-Hsiang Kao (Placentia, CA)
Assignee: Avisi Technologies, Inc.
A61F9/00781A61L27/306A61L27/34A61L2430/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,472,096
App. No.
17/423,419
Granted
Nov 18, 2025
Kind
B2
Abstract

Described herein are devices used to treat high intraocular pressure and glaucoma. An example device includes a plate comprising a first surface opposite a second surface. The first surface includes a series of fluid channels. The device also includes a first coating on the first surface and a second coating on the second surface. The device is configured to lower intraocular pressure by draining aqueous humor from an anterior chamber to subconjunctival space of a patient's eye.

Claims (30)

1 . A device for lowering intraocular pressure, the device comprising:

a plate having a first end and a second end, the plate comprising a first surface opposite a second surface, wherein the first surface includes a series of fluid channels configured in an intersecting grid pattern extending from the first end to the second end of the plate,

the first end of the plate being configured for insertion into an anterior chamber of an eye, and

the second end of the plate being configured for insertion into a subconjunctival space of the eye;

a first coating on the first surface that conforms to a topography of the series of fluid channels; and

a second coating on the second surface.

2 . The device according to claim 1 , wherein the plate includes a core that has a thickness of about 50 nm to about 800 nm.

3 . The device according to claim 1 , wherein the plate is formed from a ceramic material.

4 . The device according to claim 3 , wherein the ceramic material is selected from the group consisting of alumina, silicon nitride, silica, hafnium oxide, titanium nitride, and titanium carbide.

5 . The device according to claim 1 , wherein the first coating has a thickness of about 0.1 μm to about 1 μm.

6 . The device according to claim 1 , wherein the first coating is a parylene polymer.

7 . The device according to claim 6 , wherein the parylene polymer is parylene C, parylene D, parylene N, a derivative thereof, or a combination thereof.

8 . The device according to claim 1 , wherein the first coating is a polymeric material selected from rubber, synthetic rubber, silicone polymers, parylene, thermoplastics, thermosets, polyolefins, polyisobutylene, acrylic polymers, ethylene-co-vinylacetate, polybutylmethacrylate, vinyl halide polymers, polyvinyl ethers, polyvinylidene halides, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, polyvinyl esters, acrylonitrile-styrene copolymers, ABS resins, ethylene-vinyl acetate copolymers, polyamides, alkyd resins, polycarbonates, polyoxymethylenes, polyimides, polyethers, epoxy resins, polyurethanes, rayon, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, carboxymethyl cellulose, polytetrafluororethylene, poly(ether-ether-ketone), poly lactides including PLA, PLGA, PLLA, derivatives thereof, or combinations thereof.

9 . The device according to claim 1 , wherein the second coating has a thickness of about 0.1 μm to about 1 μm.

10 . The device according to claim 1 , wherein the second coating is aluminum oxide or a parylene polymer.

11 . The device according to claim 1 , wherein the second coating includes aluminum oxide, rubber, synthetic rubber, silicone polymers, parylene, thermoplastics, thermosets, polyolefins, polyisobutylene, acrylic polymers, ethylene-co-vinylacetate, polybutylmethacrylate, vinyl halide polymers, polyvinyl ethers, polyvinylidene halides, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, polyvinyl esters, acrylonitrile-styrene copolymers, ABS resins, ethylene-vinyl acetate copolymers, polyamides, alkyd resins, polycarbonates, polyoxymethylenes, polyimides, polyethers, epoxy resins, polyurethanes, rayon, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, carboxymethyl cellulose, polytetrafluororethylene, poly(ether-ether-ketone), poly lactides such as PLA, PLGA, PLLA, derivatives thereof, or combinations thereof.

12 . The device of claim 1 , wherein the series of fluid channels includes a plurality of open-ended channels interconnected to form an intersecting network of fluid pathways.

13 . The device of claim 1 , further including a drug.

14 . A method of reducing intraocular pressure comprising:

injecting a device into an eye with high intraocular pressure, the device including a plate having a first end and a second end, the plate comprising a first surface opposite a second surface, wherein the first surface includes a series of fluid channels configured in an intersecting grid pattern extending from the first end to the second end of the plate,

the first end of the plate being configured for insertion into an anterior chamber of the eye, and

the second end of the plate being configured for insertion into a subconjunctival space of the eye,

the plate further comprising a first coating on the first surface that conforms to a topography of the series of fluid channels and a second coating on the second surface; and

treating the high intraocular pressure.

15 . The method of claim 14 , further comprising securing the device to the eye.

16 . The method of claim 15 , wherein the securing is to a sclera of the eye.

17 . The method of claim 14 , wherein at least a portion of the first surface of the plate faces a conjunctiva of the eye and at least a portion of the second surface faces a sclera of the eye.

18 . The method of claim 17 , wherein the device forms a fluid pathway that provides fluid communication between the anterior chamber of the eye and a device position.

19 . The method of claim 18 , wherein the fluid pathway comprises the series of fluid channels.

20 . The method of claim 14 , wherein treating the high intraocular pressure is a treatment for glaucoma.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2021
From: KAO, BRANDON WEI-HSIANG; JIANG, RUI JING
To: AVISI TECHNOLOGIES, INC.
Reel/Frame 056871/0923 →
Continuity (2)
Provisional Application 62794139 · Jan 18, 2019
Related Publication 20220125637A1 · Apr 28, 2022
References Cited (58)
US 6638239B1 · Bergheim et al. · 2003 [cited by applicant]
US 7207965B2 · Simon · 2007 [cited by applicant]
US 8246569B1 · Meng et al. · 2012 [cited by applicant]
US 11717440B2 · Kao et al. · 2023 [cited by applicant]
US 20040254521A1 · Simon · 2004 [cited by applicant]
US 20050184004A1 · Rodgers et al. · 2005 [cited by applicant]
US 20050267398A1 · Protopsaltis et al. · 2005 [cited by applicant]
US 20060036207A1 · Koonmen et al. · 2006 [cited by applicant]
US 20080181930A1 · Rodstrom · 2008 [cited by examiner]
US 20100249691A1 · Van Der Mooren · 2010 [cited by examiner]
US 20100331975A1 · Nissan et al. · 2010 [cited by applicant]
US 20120273689A1 · Sullivan et al. · 2012 [cited by applicant]
US 20130150773A1 · Nissan · 2013 [cited by examiner]
US 20150230983A1 · Johnson · 2015 [cited by applicant]
US 20160032230A1 · Deutsch et al. · 2016 [cited by applicant]
US 20160058615A1 · Camras · 2016 [cited by examiner]
US 20170020730A1 · Chew et al. · 2017 [cited by applicant]
US 20230372152A1 · Kao et al. · 2023 [cited by applicant]
US 20240189145A1 · Jiang et al. · 2024 [cited by applicant]
CN 108525023A · 2018 [cited by applicant]
JP 2008526371A · 2008 [cited by applicant]
JP 2012531274A · 2012 [cited by applicant]
JP 2017506139A · 2017 [cited by applicant]
WO 0006223A1 · 1998 [cited by applicant]
WO 2006074391A2 · 2006 [cited by applicant]
WO 2009085548A2 · 2009 [cited by applicant]
WO 2010026557A2 · 2010 [cited by applicant]
WO 2010111528A2 · 2010 [cited by applicant]
WO 2010151779A1 · 2010 [cited by applicant]
WO 2015126332A1 · 2015 [cited by applicant]
WO 2016003294A1 · 2016 [cited by applicant]
WO 2016044173A1 · 2016 [cited by applicant]
WO 2016140334A1 · 2018 [cited by applicant]
WO 2018156687A1 · 2018 [cited by applicant]
WO 2019147609A2 · 2019 [cited by applicant]
WO 2020150657A1 · 2020 [cited by applicant]
WO 2022212851A1 · 2022 [cited by applicant]
Notification of Reasons for Rejection, dated Oct. 31, 2023, for related Japanese Patent Application No. 2021-541251, with English translation attached. [cited by applicant]
Extended European Search Report of European Patent Application No. 20741953.2 dated Sep. 9, 2022. [cited by applicant]
International Search Report of PCT/US2020/014173 dated Apr. 23, 2020. [cited by applicant]
Written Opinion of PCT/US2020/014173 dated Apr. 23, 2020. [cited by applicant]
First Office Action, dated Jun. 6, 2017, for related Chinese Patent Application No. 202080021797.7, with English translation attached. [cited by applicant]
Second Office Action, dated Apr. 26, 2024, for related Chinese Patent Application No. 202080021797.7, with English translation attached. [cited by applicant]
Third Office Action, dated Sep. 30, 2024, for related Chinese Patent Application No. 202080021797.7, with English translation attached. [cited by applicant]
International Search Report and Written Opinion, dated Apr. 23, 2019, for International Application Serial No. PCT/US2019/014663 filed Jan. 23, 2019. [cited by applicant]
First Examiner's Report, mailed Feb. 7, 2025, for Canadian Patent Application No. 3089342. [cited by applicant]
Supplementary European Search Report mailed Sep. 16, 2021 for European Patent Application No. 19743528.2. [cited by applicant]
International Search Report and Written Opinion, dated Sep. 12, 2022, for International Application Serial No. PCT/US2022/023064, filed Apr. 1, 2022. [cited by applicant]
Office Action, mailed Jan. 31, 2025, for related European Application No. 20741953.2. [cited by applicant]
First Examiner's Report, mailed Nov. 21, 2024, for related Australian Patent Application No. 2020207944. [cited by applicant]
First Examiner's Report, mailed dated Feb. 4, 2025, for related Canadian Patent Application No. 3126939. [cited by applicant]
Notification of Decision of Rejection, dated Sep. 3, 2024 for related Japanese Patent Application No. 2024-541251, with English translation attached. [cited by applicant]
Notification of Decision of Rejection, dated Feb. 21, 2023, for Japanese Patent Application No. 2020-561580, with English translation attached. [cited by applicant]
Notification of Decision of Rejection, dated Sep. 19, 2023, for Japanese Patent Application No. 2020-561580, with English translation attached. [cited by applicant]
Office Action, mailed May 23, 2024, for European Application No. 19743528.2. [cited by applicant]
First Office Action, dated Feb. 27, 2024, for related Chinese Patent Application No. 201980020255.5, with English translation attached. [cited by applicant]
Second Office Action, dated May 21, 2024, for related Chinese Patent Application No. 201980020255.5, with English translation attached. [cited by applicant]
Third Office Action, dated Jan. 11, 2025, for related Chinese Patent Application No. 201980020255.5, with English translation attached. [cited by applicant]